New Investigator Opportunities

LDN Fellows, Past and Present

Name Period of Training Institution Awards/Programs
Julie Eisengart, PhD 2009-2010 University of Minnesota LDN Fellow; 9/2009 LDN Fellowship in Pediatric Neuropsychology; 12/2009 National Institutes of Health, Office of Rare Diseases, Conference Travel Award; 9/2010 Rare Diseases Clinical Research Network, Conference Travel Award; 2010 CCRRD LDN Trainee Participation
Jeanine Utz, PharmD 2009-2011 University of Minnesota LDN Fellow; 2010 and 2012 CCRRD LDN Trainee Participation
Moin Vera, MD, PhD 2010 Harbor-UCLA Medical Center LDN Fellow; Ruth L. Kirschstein NRSA Award;  2010 CCRRD LDN Trainee Participation
Jonica Hazaert, PharmD 2010-2012 University of Minnesota LDN Fellow; Co-sponsored by Sanofi Genzyme
Sarah Lo, MD 2011-2012 Yale University LDN Fellow
Wenyong Tong, PhD 2012 University of California San Diego LDN Fellow; 2012 CCRRD LDN Trainee Participation
Alia Ahmed, MD 2012-2013 University of Minnesota LDN Fellow; National MPS Society grant; 10/2012 Rare Diseases Clinical Research Network, Conference Travel Award; 2012 CCRRD LDN Trainee Participation
Patrick Sorgen, PharmD 2013-2014 University of Minnesota LDN Fellow; Co-sponsored by Sanofi Genzyme
Kelly King, PhD 2013-2014 University of Minnesota LDN Fellow
Lisa Coles, MS, PhD 2013-2014 University of Minnesota LDN Fellow
Zoheb Kazi, MBBS 2013-2014 Duke University LDN Fellow; 2016 CCRRD LDN Trainee Participation
Joseph Schneider, PharmD 2014-2015 University of Minnesota LDN Fellow; Co-sponsored by Sanofi Genzyme; 2016 CCRRD LDN Trainee Participation
Mari Mori, MD 2014-2015 Duke University LDN Fellow; 2016 CCRRD LDN Trainee Participation
Melani Solomon, PhD 2015-2016 University of Maryland LDN Fellow; 2016 CCRRD LDN Trainee Participation
Zahra Karimian, PharmD 2015-2016 University of Minnesota LDN Fellow; Co-sponsored by Sanofi Genzyme
Li Ou, PhD 2016-2017 University of Minnesota LDN Fellow; 2016 CCRRD LDN Trainee Participation
Kwangchae Yoon, PharmD 2016-2018 University of Minnesota LDN Fellow; Co-sponsored by Sanofi Genzyme; 2016 CCRRD LDN Trainee Participation
Michael Flanagan, PhD 2016-2017 St. Louis University LDN Fellow; RDCRN Scholar Program; 2016 CCRRD LDN Trainee Participation
Reena Kartha, PhD 2016-2017 University of Minnesota LDN Fellow; RDCRN Scholar Program; 2012 and 2016 CCRRD LDN Trainee Participation; University of Minnesota CTSI 2017 Junior Mentor of the Year
Laura Adang, MD, PhD 2017-2018 Children’s Hospital of Philadelphia LDN Fellow; RDCRN Scholar Program; 2018 CCRRD LDN Trainee Participation
Ankit Desai, MBBS 2018-2019 Duke University LDN Fellow
Reena Kartha, PhD 2018-2019 University of Minnesota LDN Fellow; 2018 CCRRD LDN Trainee Participation
Todd Vanyo, PharmD 2018-2019 University of Minnesota LDN Fellow
Michael Przybilla, PhD 2019- University of Minnesota LDN Fellow

To learn more about past LDN Fellows, read the LDN Fellowship articles in the March 2015 and October 2015 issues of Indications, the newsletter of the Lysosomal Disease Network.

About the LDN Fellowship

Utilizing NIH funding, the Lysosomal Disease Network Fellowship provides $50,000 total costs (direct and indirect costs) for an annual period beginning August 1 of any given year to July 31 of the following year. The LDN Fellowship can support currently-ongoing research projects, as well as new research projects. The projects are required to be of a clinical nature, working with people or human tissues; they cannot be non-human medical research.

Applicant Criteria:

  1. Applicants should be a recent post-doctoral professional who will develop an interest in clinical research of lysosomal diseases. This could include physicians with training in relevant disciplines, as well as pharmacists, psychologists, or other suitably qualified professionals (i.e., MD, PhD, MD PhD, DO, PsyD, DDS, PharmD, DNP, etc.). Again, please note that this is a clinical research fellowship, not a bench research position, unless human specimens are a key aspect of the proposal.
  2. Applicants must identify a mentor with an appropriate track record in lysosomal disease research.
  3. Applicants need not be United States citizens, but must be allied with a United States-based institution qualified to receive funds from the National Institutes of Health.
  4. Applicants should use the NIH PHS 398 forms, but with these modifications:
    1. Research Plan, total of 2 page limit (plus literature cited on additional page(s))
    2. Training Plan written by applicant (goals, possible coursework/workshops, clinical activity, symposia)
    3. Role of Mentor in this research project
    4. Letter of Support from Mentor
    5. Description of research environment and resources relevant to this training program and research project (no more than one page)
  5. Biosketches are required – on NIH PHS 398 forms
    1. PI (the applicant)
    2. Mentor
  6. Cannot be based at the University of Minnesota, as one fellowship has already been awarded at this institution.

SUBMISSION DEADLINE: In any given year, the usual application deadline is May 1st, although this could possibly vary. Incomplete or late applications are not accepted for review.

Completion of Forms:
Although the current NIH PHS 398 forms must be used (including Face Page, Budget and Budget Justification pages, etc.), the grant will be issued by the University of Minnesota to the applicant’s institution.

The fellowship application does not need to be vetted by the applicant’s institutional administration prior to submission.

The application should cite additional funds, if any, that will be used to support the applicant and the research project prior to, during, and after the Fellowship, in the “Other Support” section of the application (in the Biographical Sketch).

The current PHS 398 forms are available at this website: NIH PHS 398 forms

Application Review Criteria:
Be aware that it is especially important to abide by this applicant criteria: Applicants should be a recent post-doctoral professional who will develop an interest in clinical research of lysosomal diseases. Applications will be reviewed for focus on “clinical research” (using human subjects and/or human tissues) of “lysosomal diseases” with priority given to those applicants who are likely to be mentored into a career with a focus on clinical research of lysosomal diseases.  The application will also be evaluated with respect to the applicant’s potential to submit a manuscript based on the research proposal to a peer-reviewed journal for publication.

Applications are required to be submitted by e-mail only (please do not send paper copies) by the specified deadline to this e-mail address: fellowship@nulllysosomaldiseasenetwork.org. Questions can also be sent to that e-mail address. Thank you for your interest in this Fellowship.

About the RDCRN Scholar Program

The Rare Diseases Clinical Research Network (RDCRN) annually offers early-career rare disease researchers an excellent funded training and networking opportunity. This academic-year-long course consists of both in-person and remote sessions providing the tools and mentoring needed for a successful career in rare diseases clinical research. This competitive opportunity is available to researchers associated with one of the RDCRN’s research consortia. The Lysosomal Disease Network is one such RDCRN consortium.